Telix Advances Development of Glioblastoma Therapy Program

Go back to Telix Advances Development of Glioblastoma Therapy Program
TRANS-LUX CORPORATION (NASDAQ: TLX) Delayed: 9.51 --0 (-0%)
Previous Close $9.51    52 Week High $2.18 
Open $9.51    52 Week Low $0.30 
Day High $9.51    P/E N/A 
Day Low $9.51    EPS $-3.32 
Volume 40